| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 13466-32-5 | | acetophenone, dimethylhydrazone | | | | |
| 13466-35-8 | 3-氯-2-羟基吡啶 | 3-Chloro-2(1H)pyridone | C5H4ClNO | 129.54 | | |
| 13466-38-1 | 5-溴-2-羟基吡啶 | 5-Bromo-2(1H)-pyridone | C5H4BrNO | 173.99 | 172-183℃ | |
| 13466-40-5 | | 5-phenyl-4-pentadienal | | | | |
| 13466-41-6 | 2-羟基-4-甲基吡啶 | 4-Methyl-2(1H)-pyridinone | C6H7NO | 109.12 | 131-134℃ | 186℃(12 |
| 13466-43-8 | | 3-bromo-2-hydroxypyridine | C5H4BrNO | 173.99 | | |
| 13466-78-9 | 3,7,7-三甲基二环[4.1.0]庚-3-烯 | isodiprene | C10H16 | 136.23 | | 168℃ |
| 1346600-29-0 | 埃索美拉唑杂质21 | esomeprazole impurity 21 | | | | |
| 1346600-38-1 | 文拉法辛杂质14 | venlafaxine impurity 14 | | | | |
| 1346600-54-1 | 格列吡嗪杂质d | glipizide impurity d | | | | |
| 1346600-69-8 | 单(3-羧基丙基)邻苯二甲酸酯-d4 | mono(3-carboxypropyl) phthalate-d4 | | | | |
| 1346600-85-8 | 唑吡坦usp rc a(唑吡坦ep杂质a) | zolpidem usp rc a(zolpidem ep impurity a) | | | | |
| 1346600-86-9 | 美索巴莫-d3 溶液 | methocarbamol-d3 solution | | | | |
| 1346600-92-7 | 苯乙醇胺a盐酸盐 | 2-(4-(4-nitrophenyl)butan-2-ylamino)-1-(4-methoxyphenyl)ethanol hydrochloride | | | | |
| 1346601-18-0 | 美沙拉胺-d3 | mesalamine-d3 | | | | |
| 1346601-19-1 | 比索洛尔杂质23 | bisoprolol impurity 23 | | | | |
| 1346601-20-4 | | malathion diacid-(dimethyl-d6) | | | | |
| 1346601-55-5 | 文拉法辛杂质10 | venlafaxine impurity 10 | | | | |
| 1346601-76-0 | | oxcarbazepine related compound a | | | | |
| 1346602-28-5 | 利培酮ep杂质e | risperidone ep impurity e | | | | |
| 1346602-34-3 | | prochlorperazine related compound a | | | | |
| 1346602-48-9 | | toltrazuril sulfon-(n-methyl-d3) | | | | |
| 1346602-50-3 | 吗丁啉ep杂质e | domperidone ep impurity e | | | | |
| 1346602-67-2 | 西地那非二聚体 | sildenafil dimer | | | | |
| 1346602-84-3 | 卡巴拉汀相关化合物f | rivastigmine related compound f | | | | |
| 1346603-00-6 | 安非他酮杂质20 | bupropion impurity 20 | | | | |
| 1346603-62-0 | 左氧氟沙星二胺衍生物 | levofloxacin diamine derivative | | | | |
| 1346603-71-1 | | 10-(1-methylpiperidin-4-ylidene)-5,10-dihydro-4h-benzo[5,6]cyclohepta[1,2-b]thiophen-4-one fumarate | | | | |
| 1346603-80-2 | 普罗帕酮ep杂质g | propafenone ep impurity g | | | | |
| 1346603-86-8 | 利培酮ep杂质f | risperidone ep impurity f | | | | |
| 1346604-00-9 | 比索洛尔ep杂质q | bisoprolol ep impurity q | | | | |
| 1346604-13-4 | 别嘌醇杂质c | allopurinol impurity c | | | | |
| 1346604-18-9 | 奥司他韦ep杂质d | oseltamivir ep impurity d | | | | |
| 1346605-01-3 | (±)-penbutolol-(tert-butyl-d9) hydrochloride | 1-(tert-butyl-d9)amino-3-(2-cyclopentylphenoxy)-2-propanol hydrochloride | | | | |
| 1346605-38-6 | 他达拉非ep杂质h | tadalafil ep impurity h | | | | |
| 1346606-24-3 | 利培酮ep杂质j | risperidone ep impurity j | | | | |
| 1346606-44-7 | 瑞舒伐他汀4,5-脱水酸钙盐 | rosuvastatin 4,5-anhydro acid calcium salt | | | | |
| 1346606-54-9 | 毒虫畏d10 | chlorfenvinphos d10 (di(ethyl d5)) | | | | |
| 1346607-05-3 | 6-chloro-5-(2′-hydroxy-3′-methoxy[1,1′-biphenyl]-4-yl)-3-(3-methoxyphenyl)-1h-pyrrolo[3,2-d]pyrimidine-2,4(3h,5h)-dione | gsk621 | | | | |
| 1346608-64-7 | 1-甲基-1h-吡咯并[3,2-b]吡啶-3-羧酸 | 1-methyl-1h-pyrrolo[3,2-b]pyridine-3-carboxylic acid | | | | |
| 1346608-76-1 | | 4-(3-hydroxyoxetan-3-yl)benzoic acid | | | | |
| 1346617-39-7 | | 2-[(2-amino-6-oxo-1,6-dihydro-9h-purin-9-yl)methoxy]ethyl n-methyl-l-valinate hydrochloride | | | | |
| 1346623-11-7 | (2R,3S)-2-(4-(环戊基氨基)苯基)-1-(2-氟-6-甲基苯甲酰基)哌啶-3-甲酸 | (2R,3S)-2-(4-(cyclopentylamino)phenyl)-1-(2-fluoro-6-methylbenzoyl)piperidine-3-carboxylic acid | | | | |
| 134664-54-3 | | 5'-hydroxyaverantin | | | | |
| 1346641-35-7 | | wasa-yu mpaa ligand | | | | |
| 1346647-18-4 | 环己基甲基三氟硼化钾 | potassium cyclohexylmethyltrilfuoroborate | | | | |
| 134665-72-8 | | 2'-cyano-2'-deoxyarabinofuranosylcytosine | | | | |
| 1346672-30-7 | | 2,2,2-trichloro-1-(4,5,6,7-tetrahydro-1h-indol-2-yl)ethanone | | | | |
| 1346672-36-3 | 3,4,6,7,8,9-六氢吡嗪并[1,2-a]吲哚-1(2h)-酮 | 3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-1(2h)-one | | | | |
| 1346672-54-5 | 5,6,7,8-四氢-1h-苯并[b]环戊二烯并[d]噻吩-3(2h)-酮 | 5,6,7,8-tetrahydro-1h-benzo[b]cyclopenta[d]thiophen-3(2h)-one | | | | |
m.cnreagent.com